Dark | Light
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

# ![@Sarepta Avatar](https://lunarcrush.com/gi/w:26/cr:twitter::2216555822.png) @Sarepta Sarepta Therapeutics

Sarepta Therapeutics posts on X about ceo, the world, vienna, austria the most. They currently have XXXXX followers and X posts still getting attention that total XX engagements in the last XX hours.

### Engagements: XX [#](/creator/twitter::2216555822/interactions)
![Engagements Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2216555822/c:line/m:interactions.svg)

- X Week XXX -XX%
- X Month XXXXX +49%
- X Months XXXXXX +158%
- X Year XXXXXX +434%

### Mentions: X [#](/creator/twitter::2216555822/posts_active)
![Mentions Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2216555822/c:line/m:posts_active.svg)

- X Month X +60%
- X Months XX +15%
- X Year XX +86%

### Followers: XXXXX [#](/creator/twitter::2216555822/followers)
![Followers Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2216555822/c:line/m:followers.svg)

- X Week XXXXX no change
- X Month XXXXX +0.11%
- X Months XXXXX +10%
- X Year XXXXX +14%

### CreatorRank: undefined [#](/creator/twitter::2216555822/influencer_rank)
![CreatorRank Line Chart](https://lunarcrush.com/gi/w:600/cr:twitter::2216555822/c:line/m:influencer_rank.svg)

### Social Influence

**Social category influence**
[travel destinations](/list/travel-destinations)  XXXXX% [countries](/list/countries)  XXXXX%

**Social topic influence**
[ceo](/topic/ceo) 14.29%, [the world](/topic/the-world) 14.29%, [vienna](/topic/vienna) 14.29%, [austria](/topic/austria) 14.29%, [poster](/topic/poster) XXXXX%

**Top accounts mentioned or mentioned by**
[@yachmod](/creator/undefined) [@worldmusclesoc](/creator/undefined) [@investorsobserv](/creator/undefined) [@walterscottfund](/creator/undefined) [@regenxbio](/creator/undefined) [@cgt_live](/creator/undefined)
### Top Social Posts
Top posts by engagements in the last XX hours

"Read our release at"  
[X Link](https://x.com/Sarepta/status/1949941858861228126)  2025-07-28T21:15Z 6501 followers, 18.4K engagements


"Today we released our financial results for Q2 2025. Our president & CEO on Sareptas position:"  
[X Link](https://x.com/Sarepta/status/1953193306197725431)  2025-08-06T20:35Z 6501 followers, 4826 engagements


"We look forward to attending the @WorldMuscleSoc Annual Congress #WMS2025 as a Diamond Sponsor. Visit us in-person at booth X. Learn more at"  
[X Link](https://x.com/Sarepta/status/1974144280450269250)  2025-10-03T16:07Z 6501 followers, 1155 engagements


"Attending #WMS2025 We will be presenting three oral presentations and five poster presentations at the 30th Annual International Congress of the World Muscle Society taking place in Vienna Austria from Oct 7-11"  
[X Link](https://x.com/Sarepta/status/1974890787558375728)  2025-10-05T17:33Z 6501 followers, 2053 engagements


"Today we released our financial results for Q3 2025 and provided an update on clinical development programs. Visit our website to learn more"  
[X Link](https://x.com/Sarepta/status/1985454159936491959)  2025-11-03T21:08Z 6501 followers, 1672 engagements


"Today we shared an update on the prescribing information for our approved gene therapy. Read the press release: For U.S. residents"  
[X Link](https://x.com/Sarepta/status/1989424282716573879)  2025-11-14T20:04Z 6500 followers, XXX engagements


"We just announced that the U.S. FDA approved to begin dosing in Cohort X of the ENDEAVOR study to evaluate the use of an enhanced immunosuppressive regimen as part of treatment with our gene therapy for non-ambulatory patients. Read the press release:"  
[X Link](https://x.com/Sarepta/status/1993327093929693480)  2025-11-25T14:33Z 6500 followers, 3793 engagements

[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@Sarepta Avatar @Sarepta Sarepta Therapeutics

Sarepta Therapeutics posts on X about ceo, the world, vienna, austria the most. They currently have XXXXX followers and X posts still getting attention that total XX engagements in the last XX hours.

Engagements: XX #

Engagements Line Chart

  • X Week XXX -XX%
  • X Month XXXXX +49%
  • X Months XXXXXX +158%
  • X Year XXXXXX +434%

Mentions: X #

Mentions Line Chart

  • X Month X +60%
  • X Months XX +15%
  • X Year XX +86%

Followers: XXXXX #

Followers Line Chart

  • X Week XXXXX no change
  • X Month XXXXX +0.11%
  • X Months XXXXX +10%
  • X Year XXXXX +14%

CreatorRank: undefined #

CreatorRank Line Chart

Social Influence

Social category influence travel destinations XXXXX% countries XXXXX%

Social topic influence ceo 14.29%, the world 14.29%, vienna 14.29%, austria 14.29%, poster XXXXX%

Top accounts mentioned or mentioned by @yachmod @worldmusclesoc @investorsobserv @walterscottfund @regenxbio @cgt_live

Top Social Posts

Top posts by engagements in the last XX hours

"Read our release at"
X Link 2025-07-28T21:15Z 6501 followers, 18.4K engagements

"Today we released our financial results for Q2 2025. Our president & CEO on Sareptas position:"
X Link 2025-08-06T20:35Z 6501 followers, 4826 engagements

"We look forward to attending the @WorldMuscleSoc Annual Congress #WMS2025 as a Diamond Sponsor. Visit us in-person at booth X. Learn more at"
X Link 2025-10-03T16:07Z 6501 followers, 1155 engagements

"Attending #WMS2025 We will be presenting three oral presentations and five poster presentations at the 30th Annual International Congress of the World Muscle Society taking place in Vienna Austria from Oct 7-11"
X Link 2025-10-05T17:33Z 6501 followers, 2053 engagements

"Today we released our financial results for Q3 2025 and provided an update on clinical development programs. Visit our website to learn more"
X Link 2025-11-03T21:08Z 6501 followers, 1672 engagements

"Today we shared an update on the prescribing information for our approved gene therapy. Read the press release: For U.S. residents"
X Link 2025-11-14T20:04Z 6500 followers, XXX engagements

"We just announced that the U.S. FDA approved to begin dosing in Cohort X of the ENDEAVOR study to evaluate the use of an enhanced immunosuppressive regimen as part of treatment with our gene therapy for non-ambulatory patients. Read the press release:"
X Link 2025-11-25T14:33Z 6500 followers, 3793 engagements

@Sarepta
/creator/twitter::Sarepta